RVNC is on the move - up 14%. Lets find out what's happening:

Revance Therapeutics (RVNC) is trading 14% higher at $23.74 today. While it's generally been a mildly upbeat day for this part of the market, the company is flying high overhead it's peers in the Health Care sector.

-The company announced that the FDA had approved its alternative to Botox this morning
-The product is called DAXXIFY

Revance Therapeutics has been trading between a 52-week high of $30 and a 52-week low of $11.27. The stock has a market cap of $1.74 Billion.

Revance Therapeutics, Inc. is a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its next-generation neuromodulator product, DaxibotulinumtoxinA for Injection. DaxibotulinumtoxinA for Injection combines a proprietary stabilizing peptide excipient with a highly purified botulinum toxin that does not contain human or animal-based components.

As you can imagine, the internet had a few things to say about the price move. Here's a few choice comments from the Reddit Traderverse™:

Own_Tackle4514 - 2 upvotes - source
RVNC 10/21 30/22.5/20c